Joshua Spendlove in Kennewick, Washington

Medical School: Creighton University School Of Medicine
Graduation Year: 2008
The Primary Medical Specialty for Joshua Spendlove is listed as: Urology
Approximate Years of Experience: 16
PAC (PECOS ID)#: 9436370160
NPI #: 1356513014
NPI Created On: 04/02/2008
NPI Last Updated Listed as: 08/13/2020
Primary Taxonomy Code: 208800000X
License Number:
MD2014-0118
Listed Gender: Male

Forms of insurance accepted by include, but are not limited to:

• Moda Health Plan, Inc.
• Montana Health Cooperative
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Insertion of indwelling bladder catheter
2. Bladder instillation of cancer preventive, inhibiting, or suppressive agent
3. Ultrasound measurement of bladder capacity after voiding
4. Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
5. Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
6. Insertion of stent in urinary duct (ureter) using an endoscope
7. Crushing of stone in urinary duct (ureter) with stent using an endoscope
8. Automated urinalysis test
9. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
10. New patient office or other outpatient visit, typically 30 minutes
11. New patient office or other outpatient visit, typically 30 minutes
12. New patient office or other outpatient visit, typically 45 minutes
13. New patient office or other outpatient visit, typically 45 minutes
14. Established patient office or other outpatient visit, typically 15 minutes
15. Established patient office or other outpatient visit, typically 15 minutes
16. Established patient office or other outpatient, visit typically 25 minutes
17. Established patient office or other outpatient, visit typically 25 minutes
18. Initial hospital inpatient care, typically 50 minutes per day
19. Physician telephone patient service, 5-10 minutes of medical discussion
20. Bcg live intravesical instillation, 1 mg